Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Read
2032
Timeswas read the article
394
Total PDF
1441
Total HTML
197
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 March | 41 | 12 | 9 | 62 |
| 2023 February | 49 | 30 | 12 | 91 |
| 2023 January | 33 | 15 | 5 | 53 |
| 2022 December | 78 | 50 | 21 | 149 |
| 2022 November | 77 | 37 | 13 | 127 |
| 2022 October | 108 | 32 | 17 | 157 |
| 2022 September | 95 | 37 | 16 | 148 |
| 2022 August | 85 | 38 | 15 | 138 |
| 2022 July | 72 | 43 | 15 | 130 |
| 2022 June | 82 | 44 | 22 | 148 |
| 2022 May | 81 | 40 | 48 | 169 |
| 2022 April | 54 | 2 | 1 | 57 |
| 2022 March | 56 | 2 | 1 | 59 |
| 2022 February | 55 | 2 | 1 | 58 |
| 2022 January | 220 | 2 | 0 | 222 |
| 2021 December | 203 | 4 | 1 | 208 |
| 2021 November | 52 | 4 | 0 | 56 |
| 2021 October | 0 | 0 | 0 | 0 |
Show all
